UHS vs XBIO · P/E 5.9, rev $9.13B vs rev $1.5M
Universal Health Services Inc (UHS) versus Xenetic Biosciences Inc (XBIO) — a side-by-side from cached financials, not a winner call.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
Xenetic Biosciences Inc (XBIO) is a biotechnology company listed on US.
Latest reported UHS revenue for 2026-06-30 was $9.13B. Net income was $707.1M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Latest reported XBIO revenue for 2026-06-30 was $1.5M. Net income was -$1.4M. Revenue was up 81.9% from 2026-03-31 to 2026-06-30. XBIO currently screens at market cap $5.7M.
UHS currently screens at market cap $8.55B and trailing P/E 5.9. XBIO currently screens at market cap $5.7M.
Not investment advice. Open the UHS and XBIO stock pages for the full models.
Not investment advice.